|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.31 USD | +3.47% |
|
+7.79% | -3.49% |
| 07-30 | PTC Therapeutics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | PTC Q2 Swings to Profit, Revenue Rises; Ups Guidance | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Other Pharmaceuticals | +3.47% | +7.79% | -3.49% | +45.57% | +83.64% | 5.91B |  |  | |
- Stock Market
- Stocks
- PTCT Stock
- Charts PTC Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
